Paper10450985
Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
Laurin P and 7 others. Bioorg Med Chem Lett, 1999. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. Papers, record 10450985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10450985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coumarins | Major topic |
| Enzyme Inhibitors | Major topic |
| Topoisomerase II Inhibitors | Major topic |
| Anti-Bacterial Agents | |
| DNA Gyrase | |
| Drug Design | |
| Enterococcus | |
| Escherichia coli | |
| Inhibitory Concentration 50 | |
| Methicillin Resistance | |
| Microbial Sensitivity Tests | |
| Novobiocin | |
| Staphylococcus | |
| Structure-Activity Relationship |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41032102 | Choline hydroxide mediated eco-friendly synthesis of 5-arylidene thiazol-4(5H)-one clubbed coumarin: antimicrobial evaluation and in silico studies. | Naturwissenschaften | 2025 | https://conductscience.org/library/papers/41032102 | PubMed |
| 34640121 | The Synthesis and Evaluation of Aminocoumarin Peptidomimetics as Cytotoxic Agents on Model Bacterial E. coli Strains. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34640121 | PubMed |
| 32486298 | Coumarin Derivatives as New Toxic Compounds to Selected K12, R1-R4 E. coli Strains. | Materials (Basel) | 2020 | https://conductscience.org/library/papers/32486298 | PubMed |
| 28634338 | Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/28634338 | PubMed |
| 28496477 | Cytotoxic Properties of Three Isolated Coumarin-hemiterpene Ether Derivatives from Artemisia armeniaca Lam. | Iran J Pharm Res | 2017 | https://conductscience.org/library/papers/28496477 | PubMed |
| 28262031 | Antifungal and antioxidant activities of Coleonema album and C. pulchellum against skin diseases. | Pharm Biol | 2017 | https://conductscience.org/library/papers/28262031 | PubMed |
| 23819586 | New dicoumarol sodium compound: crystal structure, theoretical study and tumoricidal activity against osteoblast cancer cells. | Chem Cent J | 2013 | https://conductscience.org/library/papers/23819586 | PubMed |
| 23587363 | Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives. | Chem Cent J | 2013 | https://conductscience.org/library/papers/23587363 | PubMed |
| 23348993 | Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents. | Molecules | 2013 | https://conductscience.org/library/papers/23348993 | PubMed |
| 22749529 | Sequential posttranslational modifications program FEN1 degradation during cell-cycle progression. | Mol Cell | 2012 | https://conductscience.org/library/papers/22749529 | PubMed |
| 18347114 | Biological activities of novel gyrase inhibitors of the aminocoumarin class. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18347114 | PubMed |
| 18274603 | New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents. | Met Based Drugs | 2007 | https://conductscience.org/library/papers/18274603 | PubMed |
| 16569821 | Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16569821 | PubMed |
| 15218104 | Mass spectrometric characterization of a three-enzyme tandem reaction for assembly and modification of the novobiocin skeleton. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15218104 | PubMed |
| 15047534 | Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15047534 | PubMed |
| 11036020 | Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/11036020 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10450985
GET https://conductscience.org/api/papers/v1/10450985/authors